SCHEMBL19796747

SCHEMBL19796747

C=C(C)C(=O)Oc1cc(-c2ccc(C3CCC(CCCCC)CC3)cc2CC)ccc1OCCO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.32
PPARG P37231 4/20 0.32
DGAT1 O75907 1/20 0.32
SOAT1 P35610 1/20 0.32
CYP2C9 P11712 1/20 0.32
PPARA Q07869 2/20 0.32
MCHR1 Q99705 1/20 0.32
RAB9A P51151 2/20 0.32
TSHR P16473 1/20 0.32
FPR2 P25090 1/20 0.32
RARA P10276 2/20 0.31
RARB P10826 2/20 0.31
RARG P13631 2/20 0.31
CSF1R P07333 1/20 0.31
PPARD Q03181 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
MMP1 P03956 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797016 0.95 RARA (0.35) PTPN11PPARGDGAT1SOAT1CYP2C9
SCHEMBL19796648 0.93 FPR2 (0.34) PTPN11PPARGDGAT1SOAT1PPARA
SCHEMBL19796653 0.91 CYP2C9 (0.36) PTPN11PPARGDGAT1SOAT1CYP2C9
SCHEMBL19796632 0.89 PPARG (0.33) PPARGPPARATSHRRARARARB
SCHEMBL19797014 0.88 RARA (0.34) PTPN11PPARGDGAT1SOAT1CYP2C9
SCHEMBL19796640 0.88 TSHR (0.33) PPARGPPARATSHRRARARARB
SCHEMBL19796562 0.87 CNR2 (0.34) PPARGCYP2C9PPARATSHRFPR2
SCHEMBL19804425 0.87 CYP3A4 (0.37) PPARGCYP2C9PPARAMCHR1RAB9A
SCHEMBL22483549 0.86
SCHEMBL20171741 0.86 PPARG (0.32) PPARGPPARATSHRRARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 PTPN11 2304/4885PPARG 3314/4885DGAT1 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.